Subsequent therapy and outcomes in patients with newly diagnosed multiple myeloma experiencing disease progression after quadruplet combinations

Documenti analoghi

• Reversing the sequence: Efficacy of BCMA‐directed therapy following progression on GPRC5D ‐directed therapies in relapsed multiple myeloma
  di: Laura Joiner, et al.
  Pubblicazione: (2025)
• Decreased neutrophil function in newly diagnosed multiple myeloma patients is restored with lenalidomide therapy
  di: Sandra Askman, et al.
  Pubblicazione: (2024)
• Are there long‐term effects of combination therapy for newly diagnosed adults with ITP ?
  di: Gabrielle A. Peko, et al.
  Pubblicazione: (2025)
• Poor prognosis of newly diagnosed multiple myeloma patients with 1p32.3 deletion in single monoallelic deletion and/or in main clone
  di: Hongying You, et al.
  Pubblicazione: (2025)
• Clinical outcomes in newly diagnosed patients with Waldenström's macroglobulinaemia treated in a tertiary academic centre
  di: Maria Gavriatopoulou, et al.
  Pubblicazione: (2026)